Literature DB >> 35261661

Pharmacokinetics-Based Optimization of Phototherapy in Neonates Undergoing Treatment for Hyperbilirubinemia.

Dibyajyoti Saikia1, Subodh Kumar2, T Velpandian3, A K Deorari4, N R Biswas5, Y K Gupta5.   

Abstract

Introduction: Neonatal jaundice results from combined effects of both increased production of bilirubin and decreased hepatic excretory capacity in neonates. Since its discovery, phototherapy is the most widespread treatment used in neonatal jaundice. In this work, we try to search for a relationship between exposure to phototherapy and decrease in serum bilirubin (linearity vs proportionality).
Methods: The present research was non-randomized prospective study conducted in the Neonatal Intensive Care Unit (NICU), Department of Paediatrics, AIIMS, New Delhi, and the Department of Pharmacology, AIIMS, New Delhi, India. Subjects were recruited from neonates admitted in NICU AIIMS, which meets our selection criteria. Infants were given a low dose of either phototherapy continuously or phototherapy for the first six hours and a double dose of phototherapy for the next six hours. Samples were collected before the beginning of the study (0 hours) and then at six and 12 hours. Bilirubin concentration was measured using HPLC and (LC-MS/MS). Results and conclusion:The percentage of reduction during the 6-12-hour interval was compared with that during the 0-6-hour interval if all experimental conditions were kept unchanged. A relationship curve between percentage of reduction and irradiance was created based on the percentage of reduction in serum bilirubin during the 0-6-hour and 0-12-hour intervals. The present study suggests that the relationship between efficacy, as measured by percentage of reduction in serum bilirubin, and irradiance is unlikely to be linear. Collected data are insufficient to clearly distinguish between proportionality and saturation point, considering that the results may be possible with both of these hypotheses.

Entities:  

Year:  2021        PMID: 35261661      PMCID: PMC8897802          DOI: 10.26574/maedica.2021.16.4.603

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  14 in total

Review 1.  [Reciprocity regulation in photobiology. An overview].

Authors:  A Schindl; B Rosado-Schlosser; F Trautinger
Journal:  Hautarzt       Date:  2001-09       Impact factor: 0.751

Review 2.  Pharmacological interventions for the treatment of neonatal jaundice.

Authors:  Phyllis A Dennery
Journal:  Semin Neonatol       Date:  2002-04

Review 3.  An evidence-based review of important issues concerning neonatal hyperbilirubinemia.

Authors:  Stanley Ip; Mei Chung; John Kulig; Rebecca O'Brien; Robert Sege; Stephan Glicken; M Jeffrey Maisels; Joseph Lau
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

4.  The structure of bilirubin.

Authors:  R Bonnett; J E Davies; M B Hursthouse; G M Sheldrick
Journal:  Proc R Soc Lond B Biol Sci       Date:  1978-06-23

5.  Development of multiple activities of UDP-glucuronyltransferase in human liver.

Authors:  J E Leakey; R Hume; B Burchell
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

6.  The nature of the dose-response relationship of phototherapy for neonatal hyperbilirubinemia.

Authors:  K L Tan
Journal:  J Pediatr       Date:  1977-03       Impact factor: 4.406

7.  Developmental aspects of human hepatic drug glucuronidation in young children and adults.

Authors:  C P Strassburg; A Strassburg; S Kneip; A Barut; R H Tukey; B Rodeck; M P Manns
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

8.  Clinicoepidemiological profile and predictors of severe illness in young infants (< 60 days) reporting to a hospital in North India.

Authors:  A K Deorari; H Chellani; J B Carlin; P Greenwood; M S Prasad; A Satyavani; Jyoti Singh; Raji John; D K Taneja; P Paul; M Meenakshi; A Kapil; V K Paul; M Weber
Journal:  Indian Pediatr       Date:  2007-10       Impact factor: 1.411

9.  Brain bilirubin content is increased in P-glycoprotein-deficient transgenic null mutant mice.

Authors:  J F Watchko; M J Daood; T W Hansen
Journal:  Pediatr Res       Date:  1998-11       Impact factor: 3.756

Review 10.  Bilirubin in clinical practice: a review.

Authors:  Johan Fevery
Journal:  Liver Int       Date:  2008-05       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.